Usefulness of S100B Protein in Neurological Disorders

被引：1

作者：

Yardan, Turker ^{[1
]}

Erenler, Ali Kemal ^{[1
]}

Baydin, Ahmet ^{[1
]}

Aydin, Keramettin ^{[2
]}

Cokluk, Cengiz ^{[2
]}

机构：

[1] Ondokuz Mayis Univ, Sch Med, Dept Emergency Med, Samsun, Turkey

[2] Ondokuz Mayis Univ, Sch Med, Dept Neurosurg, Samsun, Turkey

来源：

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2011年 / 61卷 / 03期

关键词：

Neurological disorders; S100B protein; brain marker; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; SERUM S-100B PROTEIN; SUBARACHNOID ANEURYSMAL HEMORRHAGE; CHRONIC-SCHIZOPHRENIC PATIENTS; AMYOTROPHIC-LATERAL-SCLEROSIS; CALCIUM-MODULATED PROTEINS; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In recent years, there has been an increased interest in the clinical use of brain markers. The S100B is a calcium-binding peptide and is used as a parameter of glial activation and/or death in many disorders of the central nervous system (CNS). It plays important roles in normal CNS development and recovery after injury. Although S100B is mainly found in astroglial and Schwann cells, it also has extracerebral sources. S100B is a useful neurobiochemical marker of brain damage such as in circulatory arrest, stroke and traumatic brain injury. S100B is also associated with neurodegenerative diseases like Alzheimer's disease or other chronic neurological diseases. Moreover, S100B may have a potential in predicting the efficiency of treatment and prognosis. In this review, an updated overview of the role of S100B in human neurological disorders is presented.

引用

页码：276 / 281

页数：6

共 50 条

[21] Potential role of S100B in the pathophysiology of neurodegenerative disorders
Donato, R
JOURNAL OF NEUROCHEMISTRY, 2001, 77 : 17 - 17
[22] Evaluation of brain damage during movement disorders surgery with the utilization of the S100b protein
Themistocleous, M. S.
Boviatsis, E. J.
Stathis, P.
Kouyialis, A.
Psachoulia, C.
Sakas, D. E.
MOVEMENT DISORDERS, 2009, 24 : S475 - S475
[23] Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review
Kozlowski, Tomasz
Bargiel, Weronika
Grabarczyk, Maksymilian
Skibinska, Maria
BRAIN SCIENCES, 2023, 13 (09)
[24] Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders
Levchuk, Lyudmila A.
Roschina, Olga V.
Mikhalitskaya, Ekaterina V.
Epimakhova, Elena V.
Simutkin, German G.
Bokhan, Nikolay A.
Ivanova, Svetlana A.
JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (09):
[25] RAT-BRAIN S100B PROTEIN - PURIFICATION, CHARACTERIZATION, AND ION BINDING-PROPERTIES - A COMPARISON WITH BOVINE S100B PROTEIN
BAUDIER, J
LABOURDETTE, G
GERARD, D
JOURNAL OF NEUROCHEMISTRY, 1985, 44 (01) : 76 - 84
[26] Neurological deficit is predicted by S100B in children after cardiac surgery
Bar-Yosef, O.
Greidinger, D.
Iskilova, M.
Hemi, R.
Tirosh, T.
Vardi, A.
CLINICA CHIMICA ACTA, 2018, 481 : 56 - 60
[27] Identification of an S100A1/S100B target protein: Phosphoglucomutase
Landar, A
Caddell, G
Chessher, J
Zimmer, DB
CELL CALCIUM, 1996, 20 (03) : 279 - 285
[28] Cerebrospinal fluid S100B levels reflect symptoms of depression in patients with non-inflammatory neurological disorders
Uher, Tomas
Bob, Petr
NEUROSCIENCE LETTERS, 2012, 529 (02) : 139 - 143
[29] S100B and schizophrenia
Yelmo-Cruz, Silvia
Morera-Fumero, Armando L.
Abreu-Gonzalez, Pedro
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 67 (02) : 67 - 75
[30] Calcium-binding protein, S100b, in the blood as a biochemical marker of the neurological state of men in warzones
Muraviova, D., V
Buniatov, M. R.
Ushakova, G. A.
REGULATORY MECHANISMS IN BIOSYSTEMS, 2018, 9 (04) : 529 - 534

← 1 2 3 4 5 →